-+ 0.00%
-+ 0.00%
-+ 0.00%

MOONLAKE IMMUNOTHERAPEUTICS - EXPECTS FDA NOTIFICATION ON BLA REVIEW ACCEPTANCE WITHIN 60 DAYS - SEC FILING

Reuters·09/30/2026 20:22:36